Novelix Pharmaceuticals Share Price
₹24.15 +1.15 (5%)
21 Dec, 2024 19:19
Start SIP in TRIMURTHI
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month + 5%
- Over 3 Month + 15.72%
- Over 6 Month + 27.51%
- Over 1 Year + 121.56%
Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!
Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Novelix Pharmaceuticals Financials
Novelix Pharmaceuticals Technicals
EMA & SMA
Current Price
₹24.15
+
1.15
(5%)
- Bullish Moving Average 16
- Bearish Moving Average 0
- 20 Day
- ₹21.77
- 50 Day
- ₹18.92
- 100 Day
- ₹16.03
- 200 Day
- ₹13.43
Resistance and Support
24.15
- R3 24.15
- R2 24.15
- R1 24.15
- S1 24.15
- S2 24.15
- S3 24.15
Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-13 | Quarterly Results & Others | Inter-alia, 1. To take note of the Certificate of Whole Time Director & Chief Financial Officer of the Company for the quarter and half year ended 30th September 2024. |
2024-10-21 | To consider issue of Warrants | (Revised) |
2024-09-02 | Others | Inter alia, to consider 1. Amendment of Main Objects of the Company. 2. Change in name of the Company. 3. Change in the Registered Office of the Company. |
2024-08-08 | Quarterly Results | |
2024-05-28 | Audited Results |
Novelix Pharmaceuticals F&O
About Novelix Pharmaceuticals
- NSE Symbol
- TRIMURTHI
- BSE Symbol
- 536565
- ISIN
- INE314I01036
Similar Stocks to Novelix Pharmaceuticals
Novelix Pharmaceuticals FAQs
Novelix Pharmaceuticals share price is ₹24 As on 21 December, 2024 | 19:05
The Market Cap of Novelix Pharmaceuticals is ₹24 Cr As on 21 December, 2024 | 19:05
The P/E ratio of Novelix Pharmaceuticals is 1232.1 As on 21 December, 2024 | 19:05
The PB ratio of Novelix Pharmaceuticals is 3.3 As on 21 December, 2024 | 19:05
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.